News

BioDot and Scienion have formed a unique alliance to offer a Dynamic range of low volume dispensing systems.

The addition of Cellomics expands Fisher Biosciences' reach into the high-content cellular-analysis field.

Researchers are using LC/MS/MS techniques to investigate toxicity of immunosuppressive, antiviral and antibiotic drugs in their research studies.

This research has proven that the mechanism of cancer prevention in fish is remarkably similar to that of humans, including the genes involved.

The alliance will combine the research expertise and understanding of disease mechanism and pathway biology of Novartis with Alnylam's position in the field of RNAi.

The study showed that the protein PUMA frees p53 from the grip of a third protein, Bcl-xL, so p53 can activate the series of signals that triggers programmed cell suicide.

The MDVN 300 compounds hold potential to help HRPC patients who currently face largely ineffective treatment options.

The combination of specimen preparation with LMPC and the mature kit technology from Qiagen enables the user to analyze specimens far more specifically and efficiently.

Patients with a specific combination of polymorphisms in genes responsible for the production of C-reactive protein (CRP) and interleukin-6 (IL-6) suffered stroke at three times higher rate.

RNAx provides Nucleis and its customers with in vitro shRNA validation technology to complement their proprietary transgenic animal generation technology, including the “Speedy Mouse® Technology” and vice versa.